Pacific Biosciences
PACB
#7737
Rank
โ‚น41.38 B
Marketcap
โ‚น133.25
Share price
-1.43%
Change (1 day)
-4.74%
Change (1 year)

Pacific Biosciences (PACB) - Cash on Hand

Cash on Hand as of March 2026 : โ‚น26.64 Billion

According to Pacific Biosciences 's latest financial reports the company has โ‚น26.64 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Pacific Biosciences - Cash on Hand chart (from 2009 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚น25.09 B-24.99%
2024-12-31โ‚น33.45 B-36.36%
2023-12-31โ‚น52.56 B-17.75%
2022-12-31โ‚น63.90 B-17.79%
2021-12-31โ‚น77.73 B233.4%
2020-12-31โ‚น23.31 B565.93%
2019-12-31โ‚น3.50 B-51.08%
2018-12-31โ‚น7.15 B78.28%
2017-12-31โ‚น4.01 B-17.93%
2016-12-31โ‚น4.89 B-10.54%
2015-12-31โ‚น5.46 B-14.88%
2014-12-31โ‚น6.42 B-7.61%
2013-12-31โ‚น6.95 B26.24%
2012-12-31โ‚น5.50 B-41.33%
2011-12-31โ‚น9.38 B-26.16%
2010-12-31โ‚น12.71 B195.42%
2009-12-31โ‚น4.30 B-15.59%
2008-12-31โ‚น5.09 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น314.38 B 1,079.87%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น902.30 B 3,286.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น111.52 B 318.54%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
โ‚น237.63 B 791.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
โ‚น9.37 B-64.81%๐Ÿ‡บ๐Ÿ‡ธ USA